Concepedia

Maria Caceres

MC

Statistics

Publications

10

Citations

663

H-Index

10

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Barts Health NHS Trust

Brigham and Women's Hospital

Queen Mary University of London

Alnylam Pharmaceuticals (United States)

Maria Caceres is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacy, and clinical pharmacology.

ORCID

Publications per year

2007–2025

10

Publications

10

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

Colin P. Dinney, Mark B. Fisher, Neema Navai et al. · The Journal of Urology · 2013 · 121 citations · Full text

, , +16

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

George L. Bakris, Manish Saxena, Anil Gupta et al. · JAMA · 2024 · 116 citations · Full text

, , +17

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

Johan Maertens, Oliver A. Cornely, Andrew J. Ullmann et al. · Antimicrobial Agents and Chemotherapy · 2014 · 88 citations · Full text

, , +17

Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults

Dirk Schürmann, Gerd Fätkenheuer, Jacques Reynes et al. · AIDS · 2007 · 83 citations

, , +17

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia

D. Meeike Kusters, Maria Caceres, Mauricio Coll et al. · The Journal of Pediatrics · 2015 · 76 citations

, , +9

1–5 of 10